| Number of participants | ||
|---|---|---|
| Age group | ||
| 18–29 years | 1 | |
| 30–39 years | 5 | |
| 40–49 years | 8 | |
| 50–59 years | 14 | |
| 60 years and over | 8 | |
| Sex | ||
| Male | 13 | |
| Female | 23 | |
| Stakeholder group | ||
| Rheumatologist | 8 | |
| Patient | 6 | |
| Government advisor | 5 | |
| Public servant | 8 | |
| Consumer representative | 5 | |
| Pharmaceutical industry representative | 3 | |
| Clinical nurse | 1 |